Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Suter, F.
1263  Ergebnisse:
Personensuche X
?
1

Rapid decline of anti‐hepatitis C virus (HCV) antibodies fo..:

Aebi‐Popp, K ; Wandeler, G ; Salazar‐Vizcaya, L...
HIV Medicine.  19 (2018)  6 - p. 420-425 , 2018
Link: https://doi.org/10.1111/..
 
?
2

The Heterogeneous Impacts of Groundwater Management Policie..:

Hrozencik, R. A. ; Manning, D. T. ; Suter, J. F...
Water Resources Research.  53 (2017)  12 - p. 10757-10778 , 2017
Link: https://doi.org/10.1002/..
 
?
3

Who is more likely to respond to dual treatment with pegyla..:

Di Marco, V. ; Covolo, L. ; Calvaruso, V....
Journal of Viral Hepatitis.  20 (2013)  11 - p. 790-800 , 2013
Link: https://doi.org/10.1111/..
 
?
4

F-42 Gender-specific determinants of response in HCV genoty..:

Di Marco, V. ; Covolo, L. ; Calvaruso, V....
Digestive and Liver Disease.  44 (2012)  - p. S45 , 2012
Link: https://doi.org/10.1016/..
 
?
5

P.15.2 ENTECAVIR MONOTHERAPY IN 418 NUC-NAIVE PATIENTS WITH..:

Lampertico, P. ; Viganò, M. ; Soffredini, R....
Digestive and Liver Disease.  44 (2012)  - p. S184-S185 , 2012
Link: https://doi.org/10.1016/..
 
?
6

Epidemiology, characteristics, and outcome of infective end..:

Leone, S. ; Ravasio, V. ; Durante-Mangoni, E....
Infection.  40 (2012)  5 - p. 527-535 , 2012
Link: https://doi.org/10.1007/..
 
?
7

T-8 Entecavir monotherapy in 418 NUC-naive patients with ch..:

Lampertico, P. ; Viganò, M. ; Soffredini, R....
Digestive and Liver Disease.  44 (2012)  - p. S16 , 2012
Link: https://doi.org/10.1016/..
 
?
8

F-45 Rapid virologic response (RVR), IL28B single nucleotid..:

Puoti, M. ; Covolo, L. ; Nasta, P....
Digestive and Liver Disease.  44 (2012)  - p. S46 , 2012
Link: https://doi.org/10.1016/..
 
?
9

522 MAINTAINED VIRAL SUPPRESSION AND EXCELLENT SAFETY PROFI..:

Lampertico, P. ; Soffredini, R. ; Invernizzi, F....
Journal of Hepatology.  56 (2012)  - p. S206-S207 , 2012
Link: https://doi.org/10.1016/..
 
?
10

Causes of death and risk factors among HIV-infected persons..:

Leone, S. ; Gregis, G. ; Quinzan, G....
Infection.  39 (2011)  1 - p. 13-20 , 2011
Link: https://doi.org/10.1007/..
 
?
11

P.1.48: EFFECTIVENESS AND SAFETY OF TENOFOVIR DISOPROXIL FU..:

Lampertico, P. ; Viganò, M. ; Yurdaydin, C....
Digestive and Liver Disease.  43 (2011)  - p. S164 , 2011
Link: https://doi.org/10.1016/..
 
?
12

F-43 A multicenter prospective observational study to evalu..:

Di Marco, V. ; Covolo, L. ; Levrero, M....
Digestive and Liver Disease.  43 (2011)  - p. S106 , 2011
Link: https://doi.org/10.1016/..
 
?
13

F-36 Effectiveness and safety of tenofovir disoproxil fumar..:

Lampertico, P. ; Viganò, M. ; Yurdaydin, C....
Digestive and Liver Disease.  43 (2011)  - p. S103-S104 , 2011
Link: https://doi.org/10.1016/..
 
?
14

F-34 Maintained long-term suppression of HBV replication in..:

Lampertico, P. ; Viganò, M. ; Soffredini, R....
Digestive and Liver Disease.  43 (2011)  - p. S102-S103 , 2011
Link: https://doi.org/10.1016/..
 
?
15

OC.09.2: MAINTAINED LONG-TERM SUPPRESSION OF HBV REPLICATIO..:

Lampertico, P. ; Viganò, M. ; Soffredini, R....
Digestive and Liver Disease.  43 (2011)  - p. S137-S138 , 2011
Link: https://doi.org/10.1016/..
 
1-15